tirzepatide ema approval The European Medicines Agency has recommended the first oral GLP-1 treatment for weight management, offering an alternative to weekly injections. Find out more in link in bio! #OneHealthEU #EMA EMA finds no evidence GLP-1

Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., Gojkovic, S., Krezic, I., Vidovic, T., Bilic, Z., Knezevic, M., Sever, M., Lojo, N., Kokot, A., Kolovrat, M., Drmic, D., Vukojevic, J., Kralj, T., Kasnik, K.,

Overeating while on Ozempic can lead to discomfort, nausea, or vomiting due to its effect on appetite regulation

This supports that while wt loss is important for DM mgmt, wt loss is not the driver to CV outcomes

Choosing the wrong peptides can put your health at risk and prevent you from experiencing the full benefits of therapy

Weve taken legal action to protect the American public and our intellectual property and will continue to work with regulators, law enforcement, and other key stakeholders to ensure patients have access to FDA approved safe and effective medicines. Also in February, Novo Nordisk announced approval from the European Commission for a more effective dose of the injectable form of Wegovy